We report plasma enriched in physiological ligands for platelet glycoprotein (GP) VI activation, in tandem with platelet and neutrophil procoagulation, which continued beyond the duration of post-operative thromboprophylaxis in CRC/MBD patients. This evidence concerns the gene GP6 and Marchiafava-Bignami disease.